DekaBank Deutsche Girozentrale
NEO icon

DekaBank Deutsche Girozentrale’s NeoGenomics NEO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50,800
Closed -$2.48M – 1457
2021
Q3 		$2.48M Buy
50,800
+5,000
+11% +$231K 0.01% 682
2021
Q2 		$2.12M Buy
45,800
+19,000
+71% +$842K 0.01% 708
2021
Q1 		$1.2M Buy
26,800
+24,300
+972% +$1.27M ﹤0.01% 856
2020
Q4 		$132K Buy
2,500
+1,000
+67% +$45.2K ﹤0.01% 1244
2020
Q3 		$55K Buy
+1,500
New +$55.8K ﹤0.01% 1167

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DekaBank Deutsche Girozentrale's NEO Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 50,800 shares — an estimated $2.48M sold.

DekaBank Deutsche Girozentrale first reported a position in NEO in Q3 2020 and held it in 5 quarters. The position peaked at $2.48M in Q3 2021. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 50,800 NeoGenomics shares in Q4 2021, an estimated $2.48M.
  • DekaBank Deutsche Girozentrale first reported a position in NeoGenomics in Q3 2020 and held it in 5 quarters.
  • DekaBank Deutsche Girozentrale's NeoGenomics position peaked at $2.48M in Q3 2021.
  • 307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.